This sits in the "easy default to change" tier. Fragrance-free versions of shampoo, laundry detergent, lotion, and surface cleaner cost the same as the scented ones. The effort is a single round of label-reading; after that it's automatic. The catch worth knowing: a product marked unscented usually still contains fragrance — only fragrance-free is the real thing. For anyone with eczema, asthma, or unexplained headaches that come and go, this is one of the higher-leverage small changes available.
"Fragrance" is a regulatory category, not a chemical. A typical scented product contains a fragrance mixture of fifty to two hundred individual chemicals — natural plant extracts, synthetic aroma molecules, fixatives that slow how fast the scent evaporates, and solvent carriers. In the United States and most countries outside the European Union, the whole mixture is protected as a trade secret and gets one word on the label. Analysis of common fragranced products has found that more than 90% of the volatile compounds they actually emit — including chemicals regulated as hazardous air pollutants — appear nowhere on the label or the safety data sheet (Steinemann 2016).
That single word matters because the same mixture drives four pretty different kinds of harm. None of them is dramatic for most people. All of them are real.
The first is a rash. A handful of small fragrance molecules — cinnamal, eugenol, geraniol, isoeugenol, and a dozen others — slip through the skin barrier, bind to skin proteins, and get presented to the immune system. After enough exposure, the immune system decides those molecules are an enemy, and every future contact triggers eczema. This is allergic contact dermatitis, and once it's set, it's lifelong. Fragrance is the most common cosmetic cause of it worldwide (Cheng & Zug 2014).
The second is the same mechanism, but for chemicals that weren't allergens when they went into the bottle. Limonene (the citrus smell) and linalool (the lavender / wood smell) are present in 70 to 95% of scented products. Fresh from the supplier, they're mild. Left in contact with air for weeks, they oxidise into hydroperoxides — and the hydroperoxides are dramatically more allergenic than the parent compound (Dittmar & Schuttelaar 2019). That's why an old bottle of perfume or a half-empty bottle of lotion that's been open for a year can trigger a reaction the same product didn't trigger when fresh.
The third is breathing. Spray a scented cleaner, light a candle, plug in an air freshener, and dozens of fragrance VOCs get into the air you're breathing. Some directly irritate airway tissue. The more interesting effect is secondary: terpenes react with the ozone that drifts indoors from outside, and that reaction produces formaldehyde, ultrafine particles, and a class of reactive aerosols called secondary organic aerosols (Nazaroff & Weschler 2004). Your kitchen isn't just smelling like lemon — it's making small amounts of formaldehyde in real time.
The fourth is endocrine. Fragrance compositions in personal-care products commonly use diethyl phthalate (DEP) as a solvent and fixative. DEP gets onto your skin with the lotion or perfume and into your urine within hours — measured as monoethyl phthalate, MEP. DEP itself is a weak hormone-disruptor; it shows up alongside other phthalates from food packaging and PVC that have stronger effects on testosterone and fetal development. Separately, the synthetic musks that give laundry detergent and many fragrances their long-lasting "clean" smell — galaxolide and tonalide are the workhorses — accumulate in body fat and breast milk and bind hormone receptors in laboratory tests (Van der Burg et al. 2008).
How big a problem is this, really
The dermatology evidence is the strongest. A European review pulling together eighty-four patch-test studies between 1981 and 2022 found 6.81% of dermatitis-clinic patients react positively to Fragrance Mix I and 3.64% to Fragrance Mix II — the two standard screening mixtures dermatologists use. Children aren't spared: about 4% of pediatric dermatitis patients react to FM I. The rate hasn't dropped in forty years of fragrance regulation (Botvid et al. 2024).
The North American numbers are similar and add a wrinkle: the newer terpene-oxidation allergens are climbing as the older ones get reformulated out. In the 2019–2020 series, fragrance mix I came in third (12.8%) and hydroperoxides of linalool — basically aged lavender / wood essential oils — came in fourth (11.1%) (DeKoven et al. 2023). In the most recent cycle, fragrance mix I dropped to 7.9% while the hydroperoxide allergens stayed around 10% (Houle et al. 2025). Industry switched out the older ingredients; people switched to "natural" essential-oil-scented products; the rash didn't go away.
The breathing evidence is real but harder to pin down. A US nationally representative survey found that 64.3% of asthmatics reported at least one adverse health effect from fragranced consumer products — 43% breathing problems, 28% migraines, 28% outright asthma attacks. Asthmatics were almost six times more likely to report fragrance-attributed symptoms than non-asthmatics (Steinemann 2018). A four-country pooled study replicated the pattern (Steinemann & Goodman 2019). These are self-report studies, which means you can't fully separate "fragrance triggers my asthma" from "I think fragrance triggers my asthma" — but the signal is large, consistent across four independent national samples, and concentrated in the population most likely to know what triggers their lungs.
The occupational data is cleaner. Cleaning workers — domestic and professional — develop asthma at 1.5 to 2.5 times the population rate, with cleaning sprays, bleach, and pine / citrus formulations all implicated. A California surveillance program attributed about 3.8% of work-related asthma cases over two decades specifically to fragranced product exposure (Folletti et al. 2017). The US Nurses' Health Study II found nurses with heavy disinfectant and cleaning-product exposure had worse asthma control at follow-up (Dumas et al. 2019).
The endocrine evidence is precautionary but mechanistically real. Applying scented lotion or perfume measurably raises urinary MEP within hours (Wormuth et al. 2006). Polycyclic musks from fragrances and laundry products show up in human breast milk, placenta, umbilical cord blood, and fat tissue, on every continent where researchers have looked (Van der Burg et al. 2008). No prospective cohort has yet linked household fragrance exposure to a specific disease endpoint over decades; the case for concern rides on the chemistry and the body-burden measurements, not on a clean human outcome study.
What the label is actually telling you
Three things are worth unlearning before you go shopping.
"Unscented" is not the same as "fragrance-free." An unscented product can — and usually does — contain fragrance chemicals added specifically to cover up the raw smell of the surfactants, oils, or active ingredients. The fragrance is there; the product just doesn't smell of anything in particular. The reliable label phrase is fragrance-free, ideally backed by an ingredient list with no "fragrance," "parfum," "aroma," or "perfume" entry (Steinemann 2016).
"Natural" and "essential oil" products are not safer. The two most prevalent terpenes in essential oils — limonene and linalool — are precisely the compounds that oxidise into the top-ranked allergens in modern patch-test series. A "natural" lavender-scented lotion that's been sitting open in a bathroom for six months is, by the chemistry, more allergenic than a freshly made synthetic one. The pediatric data is bracing here: in one series, 18% of patch-tested children reacted to hydroperoxides of linalool — a higher rate than in adults, likely because "natural" essential-oil products get marketed for babies and kids (Bennett et al. 2020).
Fragrance allergy is not rare. The 1–3% adult prevalence in the general population sits in the same range as peanut allergy in adults. The 6.8% positive rate in dermatitis clinics is the highest of any cosmetic allergen and second only to nickel across all allergens. If you've ever had a rash that came and went and you couldn't pin down the cause, fragrance is statistically among the most likely candidates.
What keeps happening if you don't change anything
For most people, nothing dramatic. That's the honest first sentence. Fragrance exposure is not the cigarette of 2026 — it's not killing you, and there's no looming year where you suddenly pay for it. The stakes are quieter and sit in two places.
If you're one of the people who's quietly sensitised — a few percent of adults, more if you have eczema or asthma already — the rash and the headaches don't get better on their own. You spend years swapping moisturisers, blaming the laundry detergent one season and the perfume the next, convinced you have "sensitive skin" without ever connecting it to the common thread. Sensitised skin sensitises further: a damaged barrier lets more chemicals in, which leads to reactions to ingredients that wouldn't have bothered you a decade earlier. The dermatology version of this is called the allergic march, and it explains why people in their forties suddenly start reacting to products they used at twenty without trouble.
If you have asthma or migraines, the trigger you can't identify is the trigger you can't avoid. You have a bad afternoon at the office and don't know whether it was a colleague's perfume, the cleaner the night staff used, or the plug-in air freshener in the bathroom. A small but real share of work-related asthma cases trace back to fragranced products specifically; the worker often only figures it out after a long time off and a careful re-introduction (Folletti et al. 2017).
And on the population side: phthalate metabolites in your urine, polycyclic musks in your fat tissue, a small ongoing contribution to indoor formaldehyde. None of these individually rises to the level of "this is going to make you sick." All of them are exposures you didn't consent to and don't gain anything from. The cost of keeping them is mostly invisible until you have a baby, or a partner with eczema, or a respiratory illness — and then the slow accumulation matters.
How to actually go fragrance-free
The intervention is a one-time round of label-reading per product category, prioritised by how much exposure each category actually delivers. The order below puts the highest-impact swaps first; you can stop at any rung and the household is still meaningfully better than before.
One thing the EU made easier for everyone: as of July 2026, EU-sold cosmetics must disclose the presence of any of 82 individual fragrance allergens by name on the ingredient list — up from 26 under the prior rule (EU 2023/1545). The US has not made the equivalent move, but products designed for the EU market often carry the same labels worldwide. If you're choosing between a US-only brand with "fragrance" listed and an EU-compliant one that lists "limonene, linalool, geraniol," the second is showing you more, not less.
If you currently have a half-used scented product you like and you're not sensitised: finishing it is fine. The oxidation-allergen risk grows over months — a year-old open bottle of perfume or lotion is what to discard. Replace with fragrance-free.
What changes once you do
For the unsensitised majority, the felt experience is mostly nothing — which is the right answer. You weren't going to feel an everyday benefit from removing a low-level exposure that wasn't bothering you. What you get instead is a small, ongoing reduction in DEP showing up in your urine (measurable within days of switching personal-care products), in synthetic musks accumulating in your fat tissue, and in indoor formaldehyde and ultrafine particles in your home air. Nothing you'd notice, but real on the chemistry side.
For people who turn out to be sensitised — and many people don't know they are until the trigger is removed — the change is the kind that gets noticed by others first. The colleague who used to comment on your dry patches stops mentioning them. Your partner notices you're not rubbing your eyes in the evening. The eczema on the back of your hands quietly disappears over a few weeks. The morning routine no longer involves makeup over an irritated patch on your cheekbone. People with chronic mild dermatitis often only realise how much background discomfort they were tolerating after it's gone.
For asthmatics: a smaller number of days where your chest tightens for no obvious reason. The shopping mall, the hotel lobby, the freshly cleaned office bathroom — these become navigable. The reliever inhaler gets pulled out less often. None of this is dramatic; you don't notice a missing trigger the way you notice a positive intervention. But across a year, the frequency curve shifts.
For households with babies and small children: their lifetime trajectory is different. Fragrance allergy is acquired, not innate — you get sensitised by repeated exposure starting young. A child raised in a fragrance-light home has lower odds of carrying that allergy into adulthood, and lower odds of a phthalate or musk body burden during the years when those exposures matter most. This is the payoff that takes a decade to land, and the one you'll never observe directly: you can't see the rashes and asthma flares your kid didn't develop.
Who this matters most for
The general "default to fragrance-free" recommendation applies to everyone. A few groups are higher-yield enough to warrant prioritising:
- Anyone with eczema, atopic dermatitis, or "sensitive skin" that flares unpredictably. Fragrance is the most common cosmetic cause of contact eczema and one of the most common ingredient classes in the products applied to a broken-barrier skin (Cheng & Zug 2014). A six-week trial of fragrance-free everything is one of the cheapest diagnostics available.
- Asthmatics who can't fully account for their flare pattern. The 5.76× higher rate of fragrance-attributed adverse effects in asthmatics versus non-asthmatics says the population odds are real (Steinemann 2018). If air fresheners, scented laundry, and other people's perfume have ever set off symptoms, they're worth taking seriously.
- Migraine sufferers. Fragrance ranks consistently among the top reported migraine triggers in headache-clinic series. The intervention is the same; the benefit is fewer headache days.
- Pregnant women and small children. Endocrine-active exposures matter most during organogenesis, infancy, and puberty. Polycyclic musks crossing the placenta and DEP in maternal urine are precautionary signals worth taking seriously during these windows.
- Professional cleaners and healthcare workers. Highest occupational exposure intensity. Choice of product is often not theirs to make individually, but advocacy for fragrance-free institutional purchasing is well-supported by the asthma epidemiology (Folletti et al. 2017).
Where "I went fragrance-free" goes wrong in practice
The two failure modes that show up most often:
Switching products but not categories. People swap their lotion and call it done, while the laundry detergent, dryer sheets, and plug-in air freshener continue to dominate the household's actual fragrance load. Fragrance on your shirt re-emits all day; an air freshener delivers a continuous low-level exposure for everyone in the house. If the goal is real reduction, the cleaning and laundry categories matter as much as the leave-on cosmetics.
"Unscented" without checking the ingredient list. Already covered above: an unscented label does not mean a fragrance-free formula. People who switch to an "unscented" lotion and still react are often reacting to the masking fragrance. The fix is to read the ingredient list; the keyword is the literal word fragrance (or parfum, aroma, perfume) appearing anywhere on it.
A third, milder one: replacing one source with another. Some people swap synthetic fragrance for essential-oil products because they read "natural" as "safe." From the allergic-contact-dermatitis chemistry, this is a sideways move at best — essential oils are the chemical source of the most rapidly rising allergens in modern patch-test panels (Dittmar & Schuttelaar 2019). If you're switching for a health reason, fragrance-free is the destination, not essential-oil-scented.
Adjacent things worth knowing about
Fragrance is one slice of a broader indoor-air and personal-product story. A few directions you may want to look into:
- Indoor air quality more broadly — gas stove emissions, ventilation, HEPA filtration, mould. Fragrance is one input; cooking and building materials are often bigger.
- Phthalates from food packaging and PVC. The phthalates with the strongest reproductive and developmental data (DEHP, DBP) come mainly from food contact and soft plastics, not fragrance. Fragrance-DEP is a separate but smaller piece.
- Methylisothiazolinone (MI) and other cosmetic preservatives. Often the second-most-common cosmetic allergen after fragrance; frequently appears in the same products.
- Patch testing. If you have unexplained recurring eczema, a dermatologist-supervised patch test is the actual diagnostic that tells you which ingredients are the problem — not just fragrance.
- — Your daily moisturizer is one of the main ways fragrance touches skin all over. Fragrance-free versions skip the leading allergen.
- — Scented sprays, cleaners, and lotions are a common asthma trigger; going fragrance-free is one of the cheaper ways to cut flares.
- — Fragranced products are a steady source of indoor air pollution and plasticiser exposure at home.
- — Body wash is one of the biggest daily fragrance exposures hiding in plain sight.
- — Scented candles are one more place 'fragrance' hides a mix of undisclosed VOCs — and burning them makes it worse.
- — Scented sprays are a big source of hidden fragrance chemicals — fragrance-free cleaning is part of the swap.
- — Fabric softener and dryer sheets are a major hidden-fragrance source in the home.
- — Worn fragrance is the obvious source, but 'fragrance' is buried in shampoos, lotions and cleaners as well.
- — Laundry detergent is a top example of fragrance touching your skin all day; the fragrance-free swap is free.
- — That one word 'fragrance' can hide phthalates, the plasticizers worth avoiding around pregnancy.
- — Shampoo is a classic place where you pay a premium for fragrance and marketing over any real benefit.
Substance and claimed effects
"Fragrance" (or "parfum"/"aroma") is a single ingredient label that conceals a mixture of typically 50–200 individual chemicals — natural essential oils, synthetic aroma compounds, fixatives such as low-molecular-weight phthalates, polycyclic and nitro musks, terpenes (limonene, linalool, α-pinene, β-pinene), aldehydes, and solvent carriers (ethanol, acetone, diethyl phthalate). In the United States and most jurisdictions outside the EU, the specific composition is treated as trade secret and exempt from full ingredient disclosure under cosmetics and household-product labelling rules; analysis of typical fragranced products has found that over 90% of emitted volatile organic compounds (VOCs), including listed hazardous air pollutants, are not declared anywhere on label or safety data sheet (Steinemann 2016; Steinemann 2020). Added fragrance appears in perfumes and colognes, lotions, deodorants, shampoos and conditioners, soaps, laundry detergents and dryer sheets, surface cleaners, dish soaps, air fresheners and plug-ins, scented candles, and even products marketed as "unscented" (which often contain a masking fragrance to neutralise raw-material odour). Claimed consequences this entry covers: allergic contact dermatitis (the dominant cosmetic-related allergen worldwide), respiratory irritation and asthma exacerbation, migraine and headache triggers, indoor air pollution via direct VOC emission and secondary ozone chemistry, and endocrine exposure via DEP and synthetic musks. Avoiding added fragrance is the action; the entry covers what changes when a household substitutes fragrance-free across personal-care and cleaning categories.
Evidence by addressing question
Mechanism
Fragrance produces harm through four reasonably independent routes that don't share a single mechanism:
Type IV delayed hypersensitivity (contact dermatitis). Small-molecule fragrance ingredients act as haptens, binding skin proteins and being processed by Langerhans cells; on re-exposure, sensitised T cells drive an eczematous reaction. The two screening mixes used in patch-testing — Fragrance Mix I (eight components: cinnamal, cinnamyl alcohol, eugenol, isoeugenol, geraniol, hydroxycitronellal, α-amyl cinnamal, oak moss absolute) and Fragrance Mix II (six: hydroxyisohexyl 3-cyclohexene carboxaldehyde / "Lyral", citral, citronellol, coumarin, farnesol, α-hexyl cinnamal) — capture the historically dominant sensitisers but increasingly miss the modern allergen profile (Cheng & Zug 2014; Botvid et al. 2024).
Terpene autoxidation. Limonene (citrus) and linalool (lavender, bergamot, woods) — present in roughly 70–95% of fragranced products by formulation surveys — are themselves weak sensitisers in pure form. On exposure to air over weeks to months they oxidise to hydroperoxides that are several orders of magnitude more potent. A consecutive patch-test series found positive reactions to hydroperoxides of limonene in 9.4% and of linalool in 11.7%, with most reactions considered clinically relevant — meaning the patient's dermatitis was attributable to that allergen, not an incidental sensitisation (Dittmar & Schuttelaar 2019; Sukakul et al. 2022). This is why an old bottle of perfume or a long-opened bottle of lotion can trigger a reaction the same product didn't trigger when fresh.
Respiratory irritation, sensitisation, and secondary chemistry. Inhaled fragrance VOCs act as direct irritants of bronchial epithelium; the more relevant indoor-air mechanism is secondary, where terpenes react with indoor ozone (typical concentrations 5–30 ppb) to generate formaldehyde, ultrafine particulate matter, and reactive oxygen species. Plug-in air fresheners and pine/citrus cleaners under realistic use conditions generate measurable indoor formaldehyde increments via this ozonolysis pathway (Nazaroff & Weschler 2004; Steinemann 2016). Whether fragrance triggers asthma via specific IgE-mediated sensitisation or via neurogenic / irritant mechanisms remains contested for most ingredients, but the population-level association is consistent (Folletti et al. 2017).
Endocrine pathway. Diethyl phthalate (DEP) is the dominant fragrance-solvent / fixative phthalate and the main reason urinary monoethyl phthalate (MEP) concentrations rise within hours of applying scented lotion or perfume. DEP itself has weak estrogen-receptor activity in vitro; more concerning are co-exposures to DBP/DEHP from other sources that are anti-androgenic in rodent models at relevant doses. Polycyclic musks (galaxolide / HHCB and tonalide / AHTN), used at 1000+ metric-ton annual volumes, bioaccumulate in fat, breast milk, and umbilical cord blood, and show anti-androgenic, anti-estrogenic-ERβ, and anti-progestagenic activity in receptor-binding assays (Van der Burg et al. 2008; Schettler 2006; Wormuth et al. 2006).
Evidence — contact dermatitis
Fragrance is the most common cosmetic-related allergen and consistently sits in the top three of every clinic-based patch-test series worldwide; in the general (non-clinic) population, fragrance allergy prevalence is estimated at 0.7–2.6% (Cheng & Zug 2014). The European systematic review of 84 eligible studies from 1981–2022 reports pooled positive patch-test rates of 6.81% (95% CI 6.37–7.28) for Fragrance Mix I and 3.64% (95% CI 3.30–4.01) for Fragrance Mix II in dermatitis patients, with no clear time trend across four decades (Botvid et al. 2024). Paediatric prevalence is similar (4.09% FM I, 2.17% FM II) — fragrance allergy is not an adult-only phenomenon (Botvid et al. 2024; Bennett et al. 2020).
The North American Contact Dermatitis Group's 2019–2020 cycle ranked fragrance mix I third (12.8% positive) and hydroperoxides of linalool fourth (11.1%) among 4922 tested patients; M. pereirae and FM II also broke top 15 (DeKoven et al. 2023). The 2021–2022 cycle shows FM I declining to 7.9% and hydroperoxides of linalool at 10.1%, suggesting industry reformulation has shifted (not eliminated) the allergen mix toward the newer terpene-oxidation profile (Houle et al. 2025). The pediatric hydroperoxide series found positive reactions in 13.0% (limonene-HP) and 17.9% (linalool-HP) of patch-tested children — a higher rate than in adults, plausibly reflecting heavier exposure to "natural"-marketed essential-oil products and a thinner skin barrier (Bennett et al. 2020).
Clinical phenotype: typical fragrance-allergic patient is female, mid-40s, with facial or hand eczema; prevalence increases with age until ~50, then plateaus. Once sensitised, the reaction is lifelong — re-exposure produces eczema even at very low concentrations, which is why mainstream products (containing 5–20% fragrance by mass in perfumes; sub-percent levels in lotions) cause ongoing flares (Cheng & Zug 2014).
Evidence — respiratory effects and asthma
Self-reported population data from the United States, United Kingdom, Australia, and Sweden show consistent prevalence of fragrance-attributed respiratory and headache effects in the 20–35% range of the general population, rising sharply in asthmatics. In a US nationally representative survey, 64.3% of asthmatics reported one or more adverse effects from fragranced consumer products, including respiratory problems (43.3%), migraine (28.2%), and asthma attacks (27.9%); the prevalence odds ratio for any adverse effect in asthmatics vs non-asthmatics was 5.76 (95% CI 4.34–7.64) (Steinemann 2018). The four-country pooled analysis confirmed the same pattern with 57.8% of asthmatics reporting adverse effects; 36.7% reported health problems specifically from air fresheners or deodorisers (Steinemann & Goodman 2019).
The occupational literature on cleaning workers is the most rigorous corner of the respiratory evidence. Seven of nine large epidemiological studies across multiple countries found 1.5–2.5× higher asthma rates in professional cleaners, and a 12-year California work-related-asthma surveillance attributed 3.8% of confirmed work-related asthma cases (1993–2012) to fragranced product exposure specifically; cleaning sprays and pine/citrus cleaners are repeatedly implicated (Folletti et al. 2017; Steinemann 2020). The US Nurses' Health Study II prospective cohort (n=9073 nurses, no baseline asthma) found exposure to several disinfectants and cleaning categories associated with worse asthma control on follow-up; the new-onset asthma association was weaker and category-specific (Dumas et al. 2019).
The Steinemann body of work has been criticised methodologically — it is cross-sectional, relies on online survey panels and self-attributed causation, can't separate fragrance from other product chemistry (surfactants, solvents, bleach), and has been characterised by industry-aligned reviewers as fragrance-blaming where the irritant chemistry is broader. The same critique notes that the population-level signal is large and consistent across four independently fielded national samples, which is itself information.
Evidence — endocrine and reproductive
Fragrance is the dominant household source of low-molecular-weight phthalate exposure. Application of scented personal-care products produces measurable rises in urinary MEP (DEP's metabolite) within hours, and women using more scented products show consistently higher MEP urinary concentrations (Wormuth et al. 2006; Schettler 2006). The DEP-specific human reproductive evidence is mixed: cross-sectional studies in fertility-clinic populations have reported associations between higher MEP and increased sperm DNA damage and altered motility (Duty et al. 2003), but a larger cohort of fertile men found no consistent association with classical semen parameters (Thurston et al. 2016). The stronger phthalate-reproductive signals (anti-androgenic syndrome, reduced anogenital distance, hypospadias risk) attach to DEHP and DBP, where fragrance is a smaller exposure source than food packaging and PVC products.
Polycyclic musks present a different kind of evidence: low-grade in vitro receptor signal, but unambiguous human bioaccumulation. HHCB (galaxolide) and AHTN (tonalide) are detectable in breast milk, placenta, umbilical cord blood, and adipose tissue in studies from the US, Germany, China, and Korea; production volumes exceeded 1000 metric tons annually for HHCB and AHTN combined as of the mid-2000s and have grown since (Van der Burg et al. 2008; Reiner & Kannan 2006). The clinical-relevance call is muted by the fact that no large prospective human cohort has linked musk body burden to a disease endpoint — the precautionary concern rides on receptor-level activity and persistence.
Evidence — indoor air
Direct measurement studies find that fragranced products emit on average 17 VOCs per product, with 44% emitting at least one of 24 hazardous air pollutants regulated under the US Clean Air Act (acetaldehyde, formaldehyde, 1,4-dioxane, methylene chloride, toluene). "Green," "organic," or "natural" fragranced products did not differ statistically from conventional fragranced products in hazardous-VOC emissions (Steinemann 2016). Secondary chemistry compounds the primary emissions: terpenes (limonene, α-pinene, β-pinene) react with indoor ozone in seconds-to-minutes to form formaldehyde, secondary organic aerosols, and ultrafine particles. Cleaning with citrus or pine product under realistic conditions has been shown to add ~1–2 ppb formaldehyde and 1+ μg/m³ secondary aerosol indoors during and shortly after use (Nazaroff & Weschler 2004). Air freshener plug-ins running continuously are the highest sustained exposure source in a typical home.
Practice / clinical consensus
Dermatology consensus is settled: for any patient presenting with eczema of plausible product-contact distribution (face, hands, axillae, neck), patch testing is the standard workup and avoidance of fragrance is the first-line management — once sensitised, the only effective intervention is removing the allergen (Cheng & Zug 2014). Pulmonology and occupational health bodies recommend fragrance-free policies in healthcare settings, with the US CDC, many hospitals, and a growing share of healthcare facilities operating fragrance-free workplaces. The American Lung Association publishes a model fragrance-free workplace policy. The evidence base for blanket scent-free hospital policies is thinner than the policies themselves — clinical reviewers note that no RCT shows policy-induced symptom reduction, but the rationale is precautionary and the accommodation cost is low.
Community / lay evidence
Self-identified fragrance sensitivity in the US general population was estimated at 34.7% in 2009, rising in subsequent surveys; the dominant complaints are headache, breathing difficulty, and skin symptoms (Caress & Steinemann 2009; Steinemann 2020). Online communities (r/Fragrance, r/MCAS, r/Eczema, the "fragrance-free" subreddit) report consistent themes: gradual realisation that headaches/skin issues track product changes; difficulty finding truly fragrance-free alternatives because "unscented" usually contains masking fragrance; surprise at how many household products carry added fragrance once one starts reading labels. Practitioner anecdote from dermatology and occupational medicine clinics tracks the survey data well — both communities report routine and increasing fragrance-attribution among their patients.
Historical / cross-cultural
Until the late 19th century, fragrance products were small-volume luxury items based on natural extracts (animal musks, ambergris, plant absolutes), used at very low population prevalence. The 20th century saw the synthesis of stable, cheap aroma chemicals (vanillin, ionones, aldehydes — Chanel No. 5's 1921 launch being a watershed) and the move of fragrance into mass-market personal care, household cleaning, and laundry. The 1970s–2000s saw fragrance migrate from "products you spray on yourself" to ambient atmospherics (air fresheners, plug-ins, laundry-vent emissions, scented candles, "scent marketing" in retail spaces). Each step expanded population-level exposure by an order of magnitude. The epidemiologic peak in fragrance allergic contact dermatitis in patch-test series from the 1990s–2010s tracks this exposure ramp directly.
Misconceptions
The most common consumer-side misconception is that "unscented" means "fragrance-free." It rarely does — "unscented" products typically contain masking fragrance to neutralise the raw-material odour of surfactants or active ingredients (Steinemann 2016). The reliable label is the words fragrance-free, ideally backed by an ingredient list with no "fragrance"/"parfum"/"aroma" entry. A second misconception: "natural" or "essential oil" products are safer. Limonene and linalool — the two most prevalent terpenes in essential oils — are precisely the compounds that oxidise to hydroperoxides which are now top-ranked contact allergens in NACDG data (Dittmar & Schuttelaar 2019; Houle et al. 2025). A third: that fragrance allergy is "rare." 6.8% positive patch-test rate among dermatitis-clinic patients is not rare; 1–3% general-population prevalence is similar to peanut allergy in adults.
Protocol
The intervention is categorical fragrance avoidance, prioritised by exposure magnitude:
- Air fresheners and plug-ins. Highest sustained indoor exposure source; remove first. Open windows; if odour control is needed, a HEPA / activated-carbon filter or baking soda solves the original problem without VOC emission.
- Laundry detergent and dryer sheets / fabric softener. Fragrance impregnates clothing and re-emits over days; switching is high-impact and reaches the entire household at once. Dryer-sheet emissions also vent outdoors and have been measured in neighbouring properties.
- Personal care leave-on products (perfume, cologne, scented lotion, scented deodorant). Highest skin-contact intensity; dominant DEP-exposure source. Switch to fragrance-free alternatives; "free & clear" or "sensitive skin" lines exist across most major brands.
- Rinse-off products (shampoo, conditioner, body wash, dish soap). Lower per-application impact but high frequency. Fragrance-free options widely available.
- Surface cleaners. Choose unscented or low-fragrance; avoid citrus / pine formulations especially during high-ozone afternoons.
- Read labels. Look for "fragrance," "parfum," "aroma," "perfume," or any of the now-82 EU-listed allergens by name (limonene, linalool, geraniol, citronellol, eugenol, etc.). The EU's 2023/1545 amendment expanded mandatory disclosure from 26 to 82 allergens with a compliance deadline of 31 July 2026, useful even for non-EU shoppers reading EU-compliant labels (EU 2023/1545).
Contraindications
None for the avoidance intervention itself. Considerations: small children, pregnant women, asthma patients, and people with established atopic dermatitis benefit disproportionately and should be prioritised when household resources only allow partial switching. Newly opened scented products are lower allergen-risk than long-opened ones (oxidation accumulates), so if avoidance is partial, finish older bottles or discard them, then go fragrance-free on replacement.
Stakes
The continued-exposure case is gradient, not cliff. Sensitised individuals continue to flare and accumulate chronic eczema, which itself drives further skin-barrier compromise and additional sensitisations — the dermatology phenomenon of "allergic march" within personal-care exposure. Asthmatics continue to lose lung-function control intermittently from ambient exposures they can't fully avoid, with measurable workplace and quality-of-life cost. Phthalate and musk body burdens continue to accumulate with population-level reproductive and endocrine implications that the human cohort literature can't yet quantify but rodent and in vitro data flag.
Payoff
For the sensitised: avoidance often produces dramatic skin clearance over 4–12 weeks (the time for accumulated dermatitis to resolve), and asthmatics often report reduced exacerbation frequency within weeks of household switching. For the unsensitised: prevention of future sensitisation (fragrance allergy is acquired, not innate), reduced indoor formaldehyde and ultrafine-particle load, lower DEP body burden within days. The wider household benefit is invisible because there's no "before" symptom — but children growing up in low-fragrance homes have lower likelihood of acquiring fragrance ACD over their lifetime.
Out-of-scope
Forward pointers: indoor air quality more broadly (cooking, gas stoves, building materials); endocrine-disrupting chemicals from food packaging and plastics (where DEHP/DBP dominate over fragrance-DEP); methylisothiazolinone and other non-fragrance cosmetic allergens (also high-prevalence and often co-occurring); essential-oil-specific safety beyond contact dermatitis.
The credibility range
Optimist case (industry / regulatory-cautious)
The strongest pro-fragrance case: most fragrance ingredients have been used safely at scale for decades; the IFRA self-regulation framework restricts known sensitisers and continuously updates standards (51st amendment 2025, 52nd amendment 2026). Fragrance allergic contact dermatitis prevalence in the general population is 1–3%, meaning 97% of people are not clinically affected. The asthma-exacerbation epidemiology rests heavily on self-report and cannot demonstrate causation; many of the chemicals blamed are also in other product categories (citrus terpenes occur naturally in oranges). DEP has been removed from many major-brand fragrances in response to consumer pressure; the phthalate body burden has declined over the last 15 years in NHANES even as fragrance use has not declined. Polycyclic musks at the body burdens actually measured are well below any documented adverse-effect threshold in any species. Indoor formaldehyde from terpene-ozone chemistry is real but small relative to formaldehyde from building materials and combustion. The "fragrance harms everyone" framing overstates a real but contained problem and risks alienating consumers from a category that delivers genuine quality-of-life value.
Skeptic case (precautionary / environmental health)
The strongest anti-fragrance case: a single ingredient label conceals 50–200 individual chemicals, more than 90% of which are not disclosed even in safety data sheets, blocking informed consent at the consumer level. The dermatology evidence is unambiguous: fragrance is the #1 cosmetic-allergen worldwide, with 6.8% positive patch-test rates among dermatitis patients that have not declined despite four decades of regulation. The asthma signal is replicated across multiple national populations with effect sizes that — even with cross-sectional limitations — imply tens of millions of people experiencing daily symptoms attributable to a non-essential exposure. The endocrine concern is precautionary but rests on real chemistry: DEP raises MEP measurably within hours; musks bioaccumulate and show receptor activity; the relevant exposure windows (pregnancy, infancy, puberty) are the worst times for population-level uncertainty. The exposure is unconsented in shared spaces (workplaces, airplanes, retail, dryer vent into neighbour's window). The substitution cost is trivial — fragrance-free alternatives exist at the same price in every category — making this an unusually high-leverage avoidance intervention.
Author's call
The dermatology and respiratory signals are real, replicated, and clinically actionable; the endocrine signals are precautionary but mechanistically grounded. The substitution cost is low and the population is large, so the intervention earns its rank as a default "minimise" recommendation. The entry lands on the skeptic side of the credibility range without claiming individual-level high-stakes harm for the unsensitised majority: the pitch is "you probably gain a little, you definitely lose nothing, and the population-level case is strong enough that defaults should be fragrance-free." Controversy score is moderate — industry and some regulators still argue against this framing, but clinical and environmental-health bodies are aligned.
Stakeholder + incentive map
- Fragrance industry. IFRA (International Fragrance Association) and the Research Institute for Fragrance Materials (RIFM) — self-regulatory body that sets ingredient limits and funds safety research. Strong commercial incentive to defend the category; some constructive role on transparently restricting known sensitisers.
- Cosmetics and household-product manufacturers. Mixed positions. Many major brands (Unilever, P&G) now publish partial fragrance ingredient lists and offer fragrance-free SKUs in their core lines.
- Dermatology and contact-allergy societies. ESCD, ACDS — push for expanded labelling and patch-test panel updates. Aligned with environmental-health framing.
- EU regulators (DG-GROW, SCCS). Have moved most aggressively — 2023/1545 raised mandatory disclosure from 26 to 82 allergens. US FDA has not acted; CPSC has limited authority over fragrance in cleaning products.
- Occupational health and lung associations. American Lung Association, AOEC, individual hospital systems — push fragrance-free policies.
- Environmental health advocates. EWG, Made Safe, Breast Cancer Prevention Partners — frame fragrance broadly as endocrine-disruptor exposure; sometimes overstate individual risk but raise legitimate disclosure-transparency demand.
- Skeptics within toxicology. A subset of industry-affiliated reviewers argue Steinemann-style cross-sectional surveys overstate causation.
Population variability
- Sensitised vs unsensitised. The single largest divider: once positive on patch test, lifetime avoidance is required to avoid eczematous flares; for the unsensitised, the case is precautionary.
- Asthmatics. 5.76× prevalence odds ratio for any adverse effect from fragranced products vs non-asthmatics (Steinemann 2018). High-yield population for the intervention.
- Atopic dermatitis (eczema), especially children. Impaired skin barrier and higher percutaneous exposure; pediatric hydroperoxide-allergy rates run higher than adult rates (Bennett et al. 2020).
- Migraine and chemical-sensitivity populations. Disproportionately affected; fragrance is among the top reported migraine triggers in headache-clinic series.
- Pregnant women and infants. Endocrine-window concern; phthalate and musk body burdens of greatest concern during organogenesis and early life.
- Occupational cleaners and healthcare workers. Highest exposure intensity; established asthma risk.
- Women aged 40–50. Peak fragrance ACD prevalence; cumulative exposure plus skin-barrier changes.
Knowledge gaps
The major gaps: (1) no large prospective cohort linking household fragrance load to incident asthma or atopic dermatitis — the existing literature is cross-sectional or occupational; (2) no large cohort linking polycyclic-musk body burden to a disease endpoint, despite ubiquitous bioaccumulation; (3) no good intervention trial of household-level fragrance elimination measuring symptom or biomarker change — would dramatically clarify the causal picture; (4) the relative contribution of fragrance vs other product chemistry (surfactants, solvents, preservatives) to respiratory symptoms in cleaning workers is still disentangled only imperfectly; (5) limited mechanistic clarity on why some people develop sensitisation and others don't despite similar exposure (skin-barrier genetics, microbiome, cumulative dose all candidate factors). Evidence that would shift the author's call: a well-powered intervention trial showing no symptom benefit from household fragrance elimination would soften the recommendation; a definitive prospective cohort linking specific fragrance ingredients to childhood asthma incidence would strengthen it toward a higher-stakes framing.
Scope decisions and judgement calls a reviewer can't infer from the article:
- Brief coverage check. The brief named contact dermatitis, allergies, asthma, indoor air, and endocrine exposure. All five are covered end-to-end: dermatitis and allergy in mechanism / evidence / misconceptions; asthma in mechanism / evidence / audience / failure-modes; indoor air in mechanism / evidence; endocrine exposure in mechanism / evidence / payoff. None silently dropped.
- Category placement. Placed in
home(Home & Products) rather thanskin(Skin & Personal Care) because the substance crosses both personal-care and household-cleaning categories and the cross-cutting ingredient framing is the entry's whole point. A reasonable reviewer could argue forskinon the grounds that contact dermatitis is the strongest evidence; flagged for review. - Action
avoid+ cadenceas-needed. Considereddo(read as "do go fragrance-free") andknow(literacy framing). Settled onavoidbecause the actionable thing is removing an exposure; cadenceas-neededbecause the action recurs each time the reader buys a product.dailywould overstate ongoing effort once defaults are switched. - Evidence score = 4 not 5. Dermatology side is genuinely 5-tier (multiple large patch-test series, systematic review, replicated across continents). Respiratory side rests heavily on cross-sectional self-report (Steinemann body of work) and would be 3 alone. Endocrine side is mechanism + biomonitoring without prospective disease-outcome cohorts (~3). Weighted holistically to 4 — claiming 5 would inflate the weakest legs.
- Controversy score = 3. Active debate is between dermatology / environmental-health consensus (aligned with the article's position) and fragrance-industry bodies (IFRA, RIFM) plus a subset of toxicology reviewers. Not a foundational-disagreement 4; the dermatology component isn't contested.
- No contraindications. Fragrance avoidance has no medical contraindications. Considered but ruled out.
- No audience scoping in meta. The audience addressing section names higher-yield groups (asthmatics, atopic, pregnant, occupational), but the substance applies to everyone — scoping
audience.agesorgenderwould shrink reach without justification. The peak fragrance-ACD prevalence is in women 40–50, but that's a "where the diagnosed cases concentrate" finding, not a "this only matters to that group" finding. - Steinemann methodology call. The Steinemann surveys are the dominant population-level data on fragrance-attributed asthma / migraine symptoms and are also the most-criticised. The article uses the numbers, flags the cross-sectional limitation in the dossier and softens claims in the article body ("self-report studies, which means…"). Did not exclude the data — it's the only population-level evidence at this scale and the four-country replication adds weight.
- Polycyclic musks rated cautiously. Bioaccumulation is unambiguous; disease-endpoint evidence is absent. Framed as precautionary in both research and article rather than claimed as a clear harm.
- Did not cite the IFRA 51st/52nd amendments directly. The industry self-regulation framework is referenced in the dossier credibility range and stakeholder map but not in the reader-facing article — the reader's action doesn't depend on industry-side standards, only on EU label disclosure (which is cited via EU 2023/1545).
- Separate-entry candidates. Methylisothiazolinone and cosmetic preservatives as contact allergens; phthalates as a class (food packaging + plastic + cosmetics combined); indoor air quality / gas stove emissions; the patch-testing diagnostic workup itself. All flagged in
out-of-scopeas forward pointers. - Future-link candidates. When the catalogue gains entries on indoor air quality, phthalate exposure, patch testing, or cosmetic preservatives, this entry should cross-link to them.
Fragrance in Products
Trivially low. Fragrance-free SKUs are sold at essentially the same price as scented versions across every major personal-care and household-product category; in some cases (skipping air fresheners and dryer sheets entirely) avoidance reduces total spend.
Minor lifestyle shift: reading labels at first purchase, identifying that 'unscented' often contains masking fragrance and only 'fragrance-free' is reliable (Steinemann2016), finding the fragrance-free SKU within each brand. Once household defaults are switched, ongoing effort is near-zero.
Strong on the dermatology side: 84-study European systematic review with 6.81% FM I and 3.64% FM II positive patch-test prevalence (Botvid2024), replicated NACDG North American series (DeKoven2022, Houle2025), and a now-mature hydroperoxide-allergen literature (Dittmar2019, Sukakul2022, Bennett2020). Population-level respiratory and migraine epidemiology is replicated across four national samples but rests on cross-sectional self-report; endocrine signals are mechanistically grounded but lack prospective cohort confirmation of disease endpoints.
Avoidance produces clear functional improvement for the sensitised within weeks — eczema clearance over 4–12 weeks, reduced asthma exacerbation frequency in fragrance-reactive asthmatics (5.76× POR for adverse effects in asthmatics vs non-asthmatics; Steinemann2018), reduced migraine frequency in fragrance-triggered headache populations. For the unsensitised majority the felt effect is smaller; weighted as a clear named effect overall.
Indirect cumulative skin benefit via avoidance of low-grade contact dermatitis flares and accumulated barrier damage in the sensitised; not the reason to do this for most readers, but a real downstream effect over years for the 1–3% with fragrance allergy and the larger atopic-dermatitis population (ChengZug2014, Botvid2024).
Modest precautionary contribution via reduced phthalate (DEP) and synthetic musk (HHCB/AHTN) body burden and reduced indoor formaldehyde/ultrafine-particle exposure (Steinemann2016, VanDerBurg2008, Schettler2006). No prospective cohort yet links household fragrance load to mortality; rated as marginal additive effect.
Migraine and headache trigger-removal in fragrance-sensitive populations (~28% of asthmatics report fragrance-attributed migraine; Steinemann2018) yields a small but real mood lift via fewer headache days. No general-population mood effect.